• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过各种方法制备无定形固体分散体时,研究和关联药物-聚合物的混合和分子相互作用。

Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.

机构信息

School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, United States.

School of Pharmacy, MCPHS University, Boston, MA 20115, United States.

出版信息

Eur J Pharm Sci. 2015 Apr 25;71:12-24. doi: 10.1016/j.ejps.2015.02.003. Epub 2015 Feb 14.

DOI:10.1016/j.ejps.2015.02.003
PMID:25686597
Abstract

Curcumin (CUR) was used as a poorly soluble drug whereas polyvinyl pyrrolidone K90 (PVP), Eudragit EPO (EPO), hydroxypropyl methylcellulose E5 (HPMC) and polyethylene glycol 8000 (PEG) were used as hydrophilic polymers. CUR polymer miscibility was evaluated by solubility parameter, melting point depression and glass transition temperature (Tg) measurements. Molecular interactions between CUR and polymers were determined by Fourier-transform infrared spectroscopy (FTIR) and Raman. Amorphous solid dispersions were prepared with CUR-polymer ratio of 70:30 (w/w) by solvent evaporation technique and were evaluated for dissolution enhancement using USP II method. Physical states of solid dispersions were characterized by X-ray diffraction (XRD) whereas thermal behaviors were investigated using modulated differential scanning calorimetry (MDSC). CUR-EPO system showed good miscibility through all the approaches, whereas immiscibility was found in other CUR-polymer systems. CUR-EPO and CUR-HPMC systems showed significant molecular interactions whereas CUR-PVP and CUR-PEG showed no molecular interactions. All solid dispersions showed significant dissolution enhancement with CUR-EPO showing highest dissolution rate during first 1h whereas CUR-HPMC was effective in maintaining high CUR concentrations for 6h. The study highlights the importance of investigating and correlating drug polymer miscibility and molecular interactions by various approaches for successful formulation of amorphous solid dispersions.

摘要

姜黄素(CUR)被用作难溶性药物,而聚乙烯吡咯烷酮 K90(PVP)、Eudragit EPO(EPO)、羟丙基甲基纤维素 E5(HPMC)和聚乙二醇 8000(PEG)则被用作亲水性聚合物。通过溶解度参数、熔点降低和玻璃化转变温度(Tg)测量评估 CUR 聚合物的混溶性。通过傅里叶变换红外光谱(FTIR)和拉曼确定 CUR 和聚合物之间的分子相互作用。通过溶剂蒸发技术将 CUR-聚合物比例为 70:30(w/w)制备无定形固体分散体,并使用 USP II 方法评估其溶解增强效果。通过 X 射线衍射(XRD)对固体分散体的物理状态进行表征,而通过调制差示扫描量热法(MDSC)研究其热行为。通过所有方法均表明 CUR-EPO 系统具有良好的混溶性,而其他 CUR-聚合物系统则表现出不混溶性。CUR-EPO 和 CUR-HPMC 系统显示出显著的分子相互作用,而 CUR-PVP 和 CUR-PEG 则没有显示出分子相互作用。所有固体分散体均显示出显著的溶解增强效果,其中 CUR-EPO 在最初 1 小时内显示出最高的溶解速率,而 CUR-HPMC 则能有效维持 6 小时内的高 CUR 浓度。该研究强调了通过各种方法研究和关联药物聚合物混溶性和分子相互作用对于成功制备无定形固体分散体的重要性。

相似文献

1
Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.通过各种方法制备无定形固体分散体时,研究和关联药物-聚合物的混合和分子相互作用。
Eur J Pharm Sci. 2015 Apr 25;71:12-24. doi: 10.1016/j.ejps.2015.02.003. Epub 2015 Feb 14.
2
Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.用于开发难溶性抗癌药物氟他胺无定形固体分散体的药物-聚合物混溶性、相互作用和沉淀抑制研究。
Drug Dev Ind Pharm. 2019 Aug;45(8):1277-1291. doi: 10.1080/03639045.2019.1606822. Epub 2019 May 21.
3
Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms.通过观察姜黄素无定形固体分散体的分子和界面相互作用来理解溶解机制。
Mol Pharm. 2017 Aug 7;14(8):2781-2792. doi: 10.1021/acs.molpharmaceut.7b00319. Epub 2017 Jul 7.
4
Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.选择合适的聚合物用于超临界流体辅助制备卡维地洛固体分散体。
Int J Pharm. 2019 Jan 10;554:190-200. doi: 10.1016/j.ijpharm.2018.11.015. Epub 2018 Nov 8.
5
Characterization and stability of solid dispersions based on PEG/polymer blends.基于 PEG/聚合物共混物的固体分散体的特性和稳定性。
Int J Pharm. 2010 May 10;390(2):165-73. doi: 10.1016/j.ijpharm.2010.01.039. Epub 2010 Feb 10.
6
Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.在制备难溶性活性药物成分的固体分散体时使用表面活性剂作为增塑剂:利用溶解度参数选择聚合物 - 表面活性剂组合并测试可加工性。
Int J Pharm. 2007 Jan 10;328(2):119-29. doi: 10.1016/j.ijpharm.2006.08.010. Epub 2006 Aug 17.
7
Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.无定形三元固体分散体的无定形稳定化与溶出度增强:具有药物 - 聚合物相互作用以产生协同效应的聚合物组合
J Pharm Sci. 2014 Nov;103(11):3511-3523. doi: 10.1002/jps.24137. Epub 2014 Sep 5.
8
Investigating crystallization tendency, miscibility, and molecular interactions of drug-polymer systems for the development of amorphous solid dispersions.研究药物-聚合物体系的结晶倾向、混溶性和分子相互作用,以开发无定形固体分散体。
Drug Dev Ind Pharm. 2021 Apr;47(4):579-608. doi: 10.1080/03639045.2021.1892747. Epub 2021 Mar 2.
9
[Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin].[羟丙基甲基纤维素醋酸琥珀酸酯/姜黄素无定形固体分散体对提高姜黄素溶出度和化学稳定性的作用]
Zhongguo Zhong Yao Za Zhi. 2019 Aug;44(15):3305-3311. doi: 10.19540/j.cnki.cjcmm.20190516.301.
10
Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.通过与亲水性聚合物共喷雾干燥开发低玻璃化转变温度(Tg)药物的完全无定形分散体。
Eur J Pharm Biopharm. 2012 Nov;82(3):572-9. doi: 10.1016/j.ejpb.2012.07.012. Epub 2012 Aug 24.

引用本文的文献

1
Design, Development, and Characterization of High Drug-Loaded Drug-Drug-Polymer Ternary Amorphous Solid Dispersions.高载药量药物-药物-聚合物三元非晶态固体分散体的设计、开发与表征
AAPS PharmSciTech. 2025 May 6;26(5):125. doi: 10.1208/s12249-025-03123-6.
2
Enhancing water solubility of phytosterols through Co-amorphization with food-grade coformers.通过与食品级共形成剂共无定形化提高植物甾醇的水溶性。
Curr Res Food Sci. 2025 Jan 21;10:100984. doi: 10.1016/j.crfs.2025.100984. eCollection 2025.
3
Enhanced Dissolution and Bioavailability of Curcumin Nanocrystals Prepared by Hot Melt Extrusion Technology.
热熔挤出技术制备的姜黄素纳米晶体的增强溶解和生物利用度。
Int J Nanomedicine. 2024 Jun 12;19:5721-5737. doi: 10.2147/IJN.S463918. eCollection 2024.
4
Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions.多变量分析溶解度参数评估盐酸雷洛昔芬制备无定形固体分散体中药物-聚合物的相容性。
AAPS PharmSciTech. 2024 Jun 6;25(5):127. doi: 10.1208/s12249-024-02844-4.
5
Synergistic effect of polymers in stabilizing amorphous pretomanid through high drug loaded amorphous solid dispersion.聚合物通过高载药量无定形固体分散体稳定无定形前托马尼德的协同效应。
Drug Deliv Transl Res. 2025 Feb;15(2):717-731. doi: 10.1007/s13346-024-01630-w. Epub 2024 Jun 5.
6
Preparation of Hot-Melt-Extruded Solid Dispersion Based on Pre-Formulation Strategies and Its Enhanced Therapeutic Efficacy.基于处方前策略的热熔挤出固体分散体的制备及其增强的治疗效果。
Pharmaceutics. 2023 Nov 30;15(12):2704. doi: 10.3390/pharmaceutics15122704.
7
Influence of Intermolecular Interactions on Crystallite Size in Crystalline Solid Dispersions.分子间相互作用对结晶性固体分散体中微晶尺寸的影响
Pharmaceutics. 2023 Oct 19;15(10):2493. doi: 10.3390/pharmaceutics15102493.
8
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
9
Polymorphic transitions in flufenamic acid-trehalose composites.氟芬那酸-海藻糖复合物中的多晶型转变
Int J Pharm X. 2023 Jul 23;6:100200. doi: 10.1016/j.ijpx.2023.100200. eCollection 2023 Dec 15.
10
Veering to a Continuous Platform of Fused Deposition Modeling Based 3D Printing for Pharmaceutical Dosage Forms: Understanding the Effect of Layer Orientation on Formulation Performance.转向基于熔融沉积建模的3D打印药物剂型连续平台:了解层取向对制剂性能的影响。
Pharmaceutics. 2023 Apr 23;15(5):1324. doi: 10.3390/pharmaceutics15051324.